Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$114.09 - $145.51 $4.56 Million - $5.82 Million
-40,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$89.45 - $129.85 $3.58 Million - $5.19 Million
40,000 New
40,000 $4.78 Million
Q3 2019

Nov 12, 2019

SELL
$61.52 - $91.1 $1.85 Million - $2.73 Million
-30,000 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$58.04 - $66.99 $1.16 Million - $1.34 Million
-20,000 Reduced 40.0%
30,000 $1.95 Million
Q1 2019

May 08, 2019

BUY
$35.52 - $62.62 $1.78 Million - $3.13 Million
50,000 New
50,000 $3.13 Million
Q4 2018

Feb 12, 2019

SELL
$35.43 - $56.29 $0 - $0
0 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$44.22 - $75.47 $707,608 - $1.21 Million
-16,002 Closed
0 $0
Q2 2018

Aug 06, 2018

SELL
$72.38 - $92.5 $1.38 Million - $1.76 Million
-18,998 Reduced 54.28%
16,002 $1.28 Million
Q1 2018

May 08, 2018

BUY
$69.46 - $88.57 $2.43 Million - $3.1 Million
35,000 New
35,000 $3.03 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Sivik Global Healthcare LLC Portfolio

Follow Sivik Global Healthcare LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.